Current status and mechanistic insights into nontarget coronary lesions in patients with diabetes and early abnormal glucose metabolism
{{output}}
The introduction of drug-eluting stents has significantly reduced the incidence of in-stent restenosis. Despite this, recurrent cardiovascular events related to untreated nontarget lesions (NTLs) are becoming more common and accounting for more than 50% of all... ...
